Global Venture Forum - IABMR :: International Association

Download Report

Transcript Global Venture Forum - IABMR :: International Association

Global Venture Forum
-the most effective way to find business partners in Japan-
BIO Industry in Japan
+Market Size+
12.5 billion USD
(2001)
240.3 billion USD
(2010)
Worldwide
2211.5 billion US$
Source: Overview of Biotechnology Strategy Council
USA 2884.6 billion US$
USA 28.8 trillion US$
Japan 240.3 billion US$
Europe 115.3 billion US$
Europe 19.2 trillion US$
Japan 12.5 billion US$
2001
Japan 16.3 billion US$
2003
2005
2010
2025
The Bio Clusters in Japan
Source: ‘The number of bio- venture companies in 2003’
by Japan Bioindustry Association
Hokkaido
the number of bio-ventures
45
Kanto Region
the number of bio-ventures
194
Kansai Region
the number of bio-ventures
77
Biotechnology Industry in the
Kansai Region
Key Sectors:
■Pharmaceuticals
■Medical Instruments
■Functional Food
Potential for the Pharmaceutical
Sector in Kansai
■Pharmas in Kansai are concentrated in Osaka
‘Doshomachi’, the center of Osaka City.
■30% of Japan’s pharmaceutical-related companies
and employees are concentrated in Kansai.
■Number of pharmas in Kansai, are equivalent to that
of U.K. or France.
■Among the top 18 pharmas for sales in Japan, 8 have
their headquarters in Kansai.
The Top 18 Pharmas in Japan
By Amount of sales for drugs:2003
1. Takeda Pharmaceutical
2. Astellas (Yamanouchi + Fujisawa)
3. Sankyo + Daiichi
4. Eisai
5. Shionogi
6. * Chugai Pharmaceutical
7. Taisho Pharmaceutical
8. * Banyu Pharmaceutical
9. Tanabe Seiyaku
10. Otsuka Pharmaceutical
11. Novartis Pharma
12. Kyowa Hakko Kogyo
13. Ono Pharmaceutical
14. Mitsubishi Pharma
15. Sumitomo Pharmaceuticals
16. GlaxoSmithKline
17. Dainippon Pharmaceutical
18. TAIHO Pharmaceutical
Foreign Affiliated Bio-related
companies in Kansai
■AstraZeneca Japan
■Eli Lilly Japan
■Schering-Plough K.K.
■Bayer Japan
■Boehringer Ingelheim
■Schering
■Organon Japan
■Nihon Medi-Physics
■Proctor & Gamble
Concentration of Bio Research Institutions
■Osaka University
(2,100 science researchers)
■Osaka University Hospital and Faculty of Medicine
(advanced medical care:1,000beds)
■National Cardiovascular Center
(100 researchers, 700beds)
■Osaka City University Medical School
■Osaka City University Medical School Hospital
■Osaka Bioscience Institute
(40 researchers)
■Biomolecular Engineering Research Institute
(60 researchers)
■Fundamental Technology Research Center for
Studies on the Creation of New Medicines
(more than 50 researchers)
High-leveled Researches
1. Osaka University
2. Kyoto University
3. Okazaki National Research Institutes
4. Kobe University
5. Nagoya University
6. National Institute of Genetics
7. Tokyo University
8. Kyushu University
9. JICHI Medical School
10. Kyoto Prefectural University of Medicine
Distinguished Researchers in
Osaka
<Immunology, Oncology>
Tadamitsu KISHIMOTO, Osaka University
Toshio HIRANO, Osaka University
Shigekazu NAGATA, Osaka University
<Biochemistry Neuroscience>
Shigetada NAKANISHI, Kyoto University
<Biochemistry>
Yasutomi NISHIZUKA, Osaka University
Masashi YANAGISAWA, Texas University (former Kyoto University)
<Immunology Molecular Cell>
Tetsuya TAGA, Kumamoto University (former Osaka University Professor)
<Pharmacology Physiology>
Tomoh MASAKI, Tsukuba University (former Kyoto University)
Focused Diseases
■
■
■
■
■
■
■
Arterial sclerosis
Ischemic heart disease
High-blood pressure
Arthritis rheumatoides
Asthma
Atopic dermatitis
Obesity
■ Diabetes
Market for the Medical Instrument
Sector
Source: Ministry of Health, Labor and Welfare
■Market Size in Japan
20 billion US$
(year 2002)
⇒ 2nd largest market in the world.
Breakdown:
●medical-treatment related equipments
(PTCA catheter, pacemaker)
●diagnostic device
(endoscope, CT, MRI)
●others
80 billion US$
44.7%
31.3%
24.0%
(year 2010)
Trends for Medical Care
■Changes in the Population Structure
Aging Society
■Changes in the Disease Structure
Acute Disease (infection)
Chronic Disease
(cancer, cardiac disorder,
cerebrovascular disease, diabetes)
Trends in Medical Care
■Changes in the quality of medical care
examination & treatment
prevention of disease
curing technology
Quality of Life
Focused types of medical
instruments
Regeneration related
Cardiovascular related
Minimally invasive
treatment
Bio- Imaging
Automotive diagnostic system
Medical examination
Internationalization
■Partnership with overseas companies
technical tie-ups
joint research and development
Application for patents for medical
instruments
Number of applications for patents: 11,537 (year 2000)
70%
60%
USA 64%
50%
40%
30%
Europe 27%
20%
10%
0%
Japan 9%
Companies in Kansai
Nipro Corporation
SANYO Electric Biomedical
Toyobo Co., Ltd.
Teijin
Kaneka Corporation
Matsushita Electric Industrial Co., Ltd.
Shimadzu Corporation
OMRON Corporation
Kyocera Corporation
Market for the
Functional Food Sector
■Market Size in Japan
4.2 billion USD
(year 2003)
60 billion USD
(year 2010)
Source: Ministry of Economy, Trade and Industry
Potential Market for the
Functional Food Sector
Skin Agin g
Alzh e ime r
Can c e r
Glome ru lar dise ase
Prostate - glan d e n large me n t
Catarac t
B ron c h itis
Asth ma
He patitis
Gastric an d du ode n al u lc e r
Oste oporosis
Ch ron ic arth ritis
Diabe te s
Isc h e mic h e art dise ase
Ce re brovasc u lar dise ase
High blood pre ssu re
0
1
2
3
4
5
6
7
8
9
10
Companies in Kansai
Suntory Limited
Gekkeikan
Glico
Ikari Sauce
Kaneka
OCCI Activities for promotion
of Bio-industry
■Study Group on Development of Functional Food
■Japan Bio-technology Business Competition
■BIO-Business School
■FORUM for Industrialization of Next Generation Medical
Systems, Medical Treatment Systems
■NANO-BIO Industrialization Seminars
■BIO Information Highway Plan-Phase II
■Bio-Delegation to USA (June 20-26, 2005)
Only Business Partnering event for foreign companies in Japan
September 12th and 13th
The Simple Concept
+CONNECT+
Business Partnering Service




GVF Secretariat Pre-Arranges individual
business meetings before the event.
Search and contact the best suited
company -> division -> personnel for the
presenting technology.
Nation-Wide promotion
12. 2 meetings per
company (8.0 pre-arranged)
Who’s in the Audience?

161 Companies, 345 People (2004)
List of Participants from the past event

Asahi Chemical Industry Co.,Ltd.  Nippon Shokubai Co.,Ltd

Shimadzu Corporation

Takeda Chemical

SUNTORY LTD.
Industries,LTD.

Sekisui Chemical Co.,Ltd.

SHIONOGI & Co.,LTD.

KANEKA Corporation

Fujisawa Pharmaceutical

Sumitomo Chemical Co.,Ltd.
Co.,Ltd.

Hitachi Chemical Co.,Ltd.

Otsuka pharmaceutical

Toyobo Co.,Ltd.
Co.,Ltd.

Kuraray Co.,Ltd.

Nippon Paint Co.,Ltd.
Result of Individual Meetings



7 companies concluded or about to conclude
Contracts.
( Technology tie ups, Joint Research, Joint
Development, Finance, etc)
10 companies continues their business
discussions.
0 company had no specific result
Quality First


Only Companies with excellent
technology are allowed to participate
after the evaluation by Nominating
Committee.
Main criteria :
Creativity of Technology and
Marketability of Products in Japan.
Success Stories from GVF03
■Software company from USA made a distribution
agreement with a major software distributor in Japan
■Agribio company from Japan, producing UBS Soil
Activator received investment from an industrial
promotion organization in Japan.
■A bio-tech company from Japan, developing innovative
technology to develop oral agents for drugs considered
difficult for oral absorption, received investment from an
investment firm.
Process
May 20th
June 20th

Application Deadline
Screening Committee Meeting &
Notification to Presenters
Audience Recruiting

Payment Deadline for Participation Fee

Presenter’s Orientation



GVF05-BIO
Mid-July
July 29th
September 11th
September 12th-13th
Participation Fee
US$1,500----The Fee Covers----Business Match-making Service
-Individual Booth ( W3.0 x L1.5 x H1.5 in meters )
-Simultaneous Interpretation for Presentation
-A Professional Interpreter for business talks for 2days
-Invitation to all GVF related events
-Nation wide promotion
Incentives and a 1-Day Industrial
Trip in Kansai
■Incentives by the Osaka City Government
(tentative)
For companies planning to set up a business base in
Osaka City, there is a chance to receive refund of the
GVF05 Participation Fee from the IBPC Osaka Investment
Promotion Center.
■ 1-Day
Industrial Trip by METI-Kansai
(tentative)
The METI-Kansai is planning to hold another industrial trip
again for the GVF Participants after the GVF05-BIO event.
How to Apply



Submit necessary documentations to appropriate
secretariat or coordinator via E-mail
Template file of Application form can be
downloaded from the WEB http://www.gvf.ne.jp/
Attachment of Presentation helps
Thank you very much!!
For further details and questions
Please contact
Ryoichi Nakano
tel: +81-6-6944-6403
e-mail: [email protected]
http://www.gvf.or.jp/e